COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants
D Martínez-Flores, J Zepeda-Cervantes… - Frontiers in …, 2021 - frontiersin.org
Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is
caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose …
caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose …
[HTML][HTML] Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination
A Watad, G De Marco, H Mahajna, A Druyan, M Eltity… - Vaccines, 2021 - mdpi.com
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of
immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines …
immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines …
Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence
S Wack, T Patton, LK Ferris - Journal of the American Academy of …, 2021 - Elsevier
Dermatologists diagnose and treat many immune-mediated inflammatory diseases (IMID).
Understanding the inherent immune dysregulation of these diseases as well as the …
Understanding the inherent immune dysregulation of these diseases as well as the …
Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile
Background The development of effective vaccines against coronavirus disease 2019 is a
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus …
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus …
Adenoviral vector-based vaccine platform for COVID-19: Current status
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …
21st century, claiming millions of lives and putting a huge burden on the global economy …
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
M Yalcinkaya, W Liu, MN Islam, AG Kotini… - Scientific reports, 2021 - nature.com
Despite the initial success of some drugs and vaccines targeting COVID-19, understanding
the mechanism underlying SARS-CoV-2 disease pathogenesis remains crucial for the …
the mechanism underlying SARS-CoV-2 disease pathogenesis remains crucial for the …
Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions
Background While vaccines ensure individual protection against COVID-19 infection, delay
in receipt or refusal of vaccines will have both individual and community impacts. The …
in receipt or refusal of vaccines will have both individual and community impacts. The …
Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19
With millions of people infected and hundreds of thousands of fatalities worldwide, the
global health and economies have been greatly affected by the COVID-19 pandemic. The …
global health and economies have been greatly affected by the COVID-19 pandemic. The …